Citations for
1MRD50, NAA10, NAA15
Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
Cheng H, Dharmadhikari AV, Varland S, Ma N, Domingo D, Kleyner R, Rope AF, Yoon M, Stray-Pedersen A, Posey JE, Crews SR, Eldomery MK, Akdemir ZC, Lewis AM, Sutton VR, Rosenfeld JA, Conboy E, Agre K, Xia F, Walkiewicz M, Longoni M, High FA, van Slegtenhorst MA, Mancini GMS, Finnila CR, van Haeringen A, den Hollander N, Ruivenkamp C, Naidu S, Mahida S, Palmer EE, Murray L, Lim D, Jayakar P, Parker MJ, Giusto S, Stracuzzi E, Romano C, Beighley JS, Bernier RA, Küry S, Nizon M, Corbett MA, Shaw M, Gardner A, Barnett C, Armstrong R, Kassahn KS, Van Dijck A, Vandeweyer G, Kleefstra T, Schieving J, Jongmans MJ, de Vries BBA, Pfundt R, Kerr B, Rojas SK, Boycott KM, Person R, Willaert R, Eichler EE, Kooy RF, Yang Y, Wu JC, Lupski JR, Arnesen T, Cooper GM, Chung WK, Gecz J, Stessman HAF, Meng L, Lyon GJ.
Am J Hum Genet 102(5):985-994. doi: 10.1016/j.ajhg.2018.03.004. Epub 2018 Apr 12. 2018
2MRD50, NAA15
Phenotypic consequences of gene disruption by a balanced de novo translocation involving SLC6A1 and NAA15.
Pesz K, Pienkowski VM, Pollak A, Gasperowicz P, Sykulski M, Kosińska J, Kiszko M, Krzykwa B, Bartnik-Głaska M, Nowakowska B, Rydzanicz M, Sasiadek MM, Płoski R.
Eur J Med Genet ur J Med Genet. 2018 Apr 3. pii: S1769-7212(18)30097-1. doi: 10.1016/j.ejmg.2018.03.013. [Epub ahead of print] 2018
3NAA15, PUF60
Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability.
Zhao JJ, Halvardson J, Zander CS, Zaghlool A, Georgii-Hemming P, Månsson E, Brandberg G, Sävmarker HE, Frykholm C, Kuchinskaya E, Thuresson AC, Feuk L.
Am J Med Genet B Neuropsychiatr Genet 177(1):10-20. doi: 10.1002/ajmg.b.32574. Epub 2017 Oct 9. 2018
4CTTN, NAA15, SRC
Tubedown regulation of retinal endothelial permeability signaling pathways.
Ho N, Gendron RL, Grozinger K, Whelan MA, Hicks EA, Tennakoon B, Gardiner D, Good WV, Paradis H.
Biol Open 4(8):970-9. doi: 10.1242/bio.010496. 2015
5NAA15
Loss of tubedown expression as a contributing factor in the development of age-related retinopathy.
Gendron RL, Laver NV, Good WV, Grossniklaus HE, Miskiewicz E, Whelan MA, Walker J, Paradis H.
Invest Ophthalmol Vis Sci 51(10):5267-77. doi: 10.1167/iovs.09-4527. Epub 2010 May 12. 2010
6CTTN, NAA10, NAA15
Tubedown associates with cortactin and controls permeability of retinal endothelial cells to albumin.
Paradis H, Islam T, Tucker S, Tao L, Koubi S, Gendron RL.
J Cell Sci 121(Pt 12):1965-72. doi: 10.1242/jcs.028597. Epub 2008 May 21. 2008
7NAA15
Tubedown-1 (Tbdn-1) suppression in oxygen-induced retinopathy and in retinopathy of prematurity.
Gendron RL, Good WV, Miskiewicz E, Tucker S, Phelps DL, Paradis H.
Mol Vis 12:108-16. 2006
8NAA10, NAA15
Identification and characterization of the human ARD1-NATH protein acetyltransferase complex.
Arnesen T, Anderson D, Baldersheim C, Lanotte M, Varhaug JE, Lillehaug JR.
Biochem J 386(Pt 3):433-43. 2005
9NAA15
NATH, a novel gene overexpressed in papillary thyroid carcinomas.
Fluge O, Bruland O, Akslen LA, Varhaug JE, Lillehaug JR.
Oncogene 21(33):5056-68. 2002
10NAA15
Tubedown-1 in remodeling of the developing vitreal vasculature in vivo and regulation of capillary outgrowth in vitro.
Paradis H, Liu CY, Saika S, Azhar M, Doetschman T, Good WV, Nayak R, Laver N, Kao CW, Kao WW, Gendron RL.
Dev Biol 249(1):140-55. 2002
11NAA15
A novel Xenopus acetyltransferase with a dynamic expression in early development.
Choi SC, Chang JY, Han JK.
Biochem Biophys Res Commun 285(5):1338-43. 2001